| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |